Transaction · 0001628280-26-070385
ARQTArcutis Biotherapeutics, Inc.
Matsuda Masaru
Matsuda Masaru, EVP, CLO, reported a transaction classified as exercise at Arcutis Biotherapeutics, Inc. involving 40000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 136000.000000 shares. The stored filing text includes a detected 10b5-1 reference.
exerciseSEC transaction code MEVP, CLO
- Trade date
- Nov 04, 2026
- Filing date
- Nov 04, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
ARQT price since this filing
Daily closing prices, with the filing date and available return windowsARQT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -26.1%1w ago -7.6%1d ago -6.0%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001628280-26-070385 Stock Option (right to buy)
- Transaction date
- Nov 04, 2026 Filed Nov 04, 2026, 11:38 PM · 0d delay
- Shares
- 40,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 136,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
EVP, Chief Legal Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- F2
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby
undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respec…
price within the range set forth in this footnote.
- F3
The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2026, by the Reporting Person, with a plan end date of September 1, 2027.
- F4
The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $34.00 to $37.7966, inclusive. The Reporting Person hereby underta…
- F5
1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be…
Related transactions
Same SEC filing0 other transactions
Recent company activity
ARQT0 recent txs